Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04942561 · ClinicalTrials.gov registry record · NA
VR to Reduce Pain/Anxiety During IV Starts
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
NCT04942561 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 107 participants.
The verdict
NCT04942561, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
Study Summary
This study aims to test the effectiveness of virtual reality (VR) as a non-pharmaceutical intervention to reduce pain and anxiety in children undergoing peripheral intravenous catheter (PIVC) access in the Department of Radiology and Imaging or the outpatient Infusion Center at CHLA, as measured by self- and proxy-report.
Interventions
- DEVICE Samsung Gear VR
- DEVICE Merge VR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2017-04-12 |
| Est. Completion | 2019-07-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04942561
The ClinicalTrials.gov registry entry for NCT04942561 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Samsung Gear VR is the first listed.
NCT04942561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04942561 about?
NCT04942561 is a clinical study titled "VR to Reduce Pain/Anxiety During IV Starts". This study aims to test the effectiveness of virtual reality (VR) as a non-pharmaceutical intervention to reduce pain and anxiety in children undergoing peripheral intravenous catheter (PIVC) access in the Department of Radiology and Imaging or the outpatient Infusion Center at CHLA, as measured by ...
What is the current status of trial NCT04942561?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2017-04-12. Estimated completion is 2019-07-24.
What interventions are being tested in trial NCT04942561?
The interventions under investigation include: Samsung Gear VR (DEVICE), Merge VR (DEVICE).
Who is sponsoring clinical trial NCT04942561?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.